Moderna, Inc. Files Form 10-Q with the U.S. Securities and Exchange Commission

Strategic Insights -

Moderna, Inc., a leading biotechnology company, has filed its Form 10-Q with the U.S. Securities and Exchange Commission (SEC) on August 3, 2023. The filing, which was reported by NewsRx journalists, includes unaudited financial statements and provides a continuing view of the company's financial position during the year. As a publicly-traded company, Moderna, Inc. is required to file the Form 10-Q for each of the first three fiscal quarters of its fiscal year, with the report due within 45 days of the close of the quarter.

Key Takeaways:

  • Moderna, Inc. filed its Form 10-Q with the U.S. Securities and Exchange Commission (SEC) on August 3, 2023.
  • The SIC code for Moderna, Inc. is 2836, Biological Products, (No Diagnostic Substances).
  • There were 92 documents filed with the Form 10-Q.
  • The SEC file number for this filing is 0001682852-23-000027.
  • Moderna, Inc. is headquartered at 200 TECHNOLOGY SQUARE, CAMBRIDGE MA 02139, with a contact phone number of 6177146500.
  • The Form 10-Q is a report filed quarterly by most reporting companies, providing unaudited financial statements and a continuing view of the company's financial position during the year.
  • The report must be filed for each of the first three fiscal quarters of the company's fiscal year and is due within 45 days of the close of the quarter.
  • The filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.

Statistics:

  • 92 documents were filed with the Form 10-Q.
  • August 3, 2023, was the date of the SEC filing.
  • 200 TECHNOLOGY SQUARE is the address of Moderna, Inc.'s headquarters.
  • 6177146500 is the contact phone number for Moderna, Inc.

Sources:

  • NewsRx - Life Science Weekly (Washington, D.C.) - August 22, 2023
  • U.S. Securities and Exchange Commission (SEC) - Form 10-Q filing (0001682852-23-000027) - August 3, 2023